HR 171 United States House · 118th Congress

HALT Fentanyl Act

The HALT Fentanyl Act classifies all fentanyl-related substances as Schedule I controlled substances, affecting researchers, medical institutions, and law enforcement. It defines fentanyl-related substances broadly to include any chemical modifications meeting specific structural criteria, such as substitutions on the phenethyl or piperidine rings. The bill establishes expedited registration processes for research on these substances conducted by or funded by HHS or VA, and clarifies that certain research-related manufacturing activities do not require separate manufacturing registrations. It also requires researchers to notify the Attorney General about research involving these substances and outlines procedures for handling substances newly added to Schedule I.

Issues: ✗ Criminal Justice

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2023

Committee Review

Floor Vote

President

Introduced Jan 9, 2023 Last action Jan 20, 2023

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jan 20, 2023

Committee

Referred to the Subcommittee on Health.

lower

Jan 9, 2023

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jan 9, 2023

Introduced

Introduced in House

lower

1 primary · 2 co-sponsors